Unraveling the mechanism of curcumin in coronary slow flow phenomenon through network pharmacology and molecular docking
Chentian Xue, Jian Kang, Qing Zhu, Xiang Gao, Xize Wu, Yue Yu · 2025
Read Unraveling the mechanism of curcumin in coronary slow flow phenomenon through network pharmacology and molecular docking by Chentian Xue, Jian Kang, Qing Zhu, Xiang Gao, Xize Wu, Yue Yu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12739133.txt.
Description
Xue and co-authors used computational pharmacology to ask how curcumin, the turmeric compound, might treat coronary slow flow, a condition where blood moves sluggishly through heart arteries and raises event risk. No standard treatment exists. The team mined public databases for curcumin's predicted targets and for genes tied to the condition, finding 19 shared targets, then mapped the interactions among them.
Five core targets emerged, including EGFR and STAT3, linked to inflammation and vessel pathways such as NF-kappaB and TNF signaling. Virtual docking showed curcumin binds all five strongly, and simulations found the complexes stable. The authors say the multi-target picture gives a theoretical base for using curcumin in this condition, while noting that lab and clinical tests must confirm it.
Catalog record
| CREATOR | Chentian Xue, Jian Kang, Qing Zhu, Xiang Gao, Xize Wu, Yue Yu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |